5 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Galida: new trials by email Literature Review of Galida trials Research Report on Galida
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus Tesaglitazar, Pioglitazone - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 1100 | 2005-03-01 | 2010-11-19 |
| GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes Tesaglitazar - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 270 | 2005-02-01 | 2010-11-19 |
| ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR) Tesaglitazar, pioglitazone - Diabetes Mellitus, Type 2 | Phase 2 | Terminated | AstraZeneca | 100 | 2004-09-01 | 2011-08-30 |
| GALLANT 6 Tesaglitazar vs. Pioglitazone Galida - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 1450 | 2004-08-01 | 2010-11-19 |
| GALLANT 5 Tesaglitazar Versus Metformin GALIDA - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | AstraZeneca | 580 | 2004-08-01 | 2010-11-19 |
AstraZeneca (5)
United States (5) · Finland (3) · United Kingdom (3) · Argentina (2) · Brazil (2) · Canada (2) · Mexico (2) · Norway (2) · Germany (1) · Israel (1) · Netherlands (1) · Spain (1)